The association of metabolic syndrome score trajectory patterns with risk of all cancer types.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Metabolic syndrome (MetS) elevates cancer risk. However, a single MetS assessment does not fully reveal the long-term association with cancer. Inflammation, alongside MetS, could synergistically expedite both the onset and advancement of cancer. This study aims to investigate MetS score trajectories and cancer risk in a large, prospective cohort study.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cancer

Title: Cancer

Publisher: Wiley

ISSN (Electronic): 1097-0142

ISSN (Print): 0008-543X

Publication date (Electronic): Jun 15 2024

Volume: 130

Issue: 12

Affiliations

[1 ] Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

[2 ] National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.

[3 ] Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China.

[4 ] Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.

[5 ] Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.

[6 ] Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.

[7 ] Department of Hepatological Surgery, Kailuan General Hospital, Tangshan, China.

[8 ] Department of General Surgery, Kailuan General Hospital, Tangshan, China.

Article

DOI: 10.1002/cncr.35235

PubMed ID: 38462898

SO-VID: 413fb805-5748-4465-952c-0eba8a61e5bd

History

Keywords: trajectory,cancer,prospective,metabolic syndrome

Data availability:

Keywords: trajectory, cancer, prospective, metabolic syndrome

Comments

Comment on this article

Cited by 5

See all cited by